AcclaimIP-ad

Match Document Document Title
9969781 Compositions and methods to treat cancer with CpG rich DNA and cupredoxins  
The present invention relates to compositions comprising CpG rich DNA from Pseudomonas aeruginosa. The compositions optionally comprise a cupredoxin. The present invention includes specific CpG...
9969715 Compounds useful for treating cancer  
The present invention relates to a compound of formula (I): wherein A and A′ independently represent a phenylene group or a pyridylene group; R2 is a hydrogen atom or a (C1-C4)alkyl group; R3 is a...
9969699 Cancer cell growth inhibitor, anticancer agent, and method for screening same, as well as novel compound  
A cancer cell proliferation inhibitor including at least one selected from compounds represented by Structural Formulae (1) to (8), wherein the cancer cell is at least one of a cancer cell...
9968685 Methods to treat cancer with cupredoxins  
The present invention discloses methods and materials for killing and/or inhibiting the growth of a cancer cell via preferential entry of a cytotoxic compound. Preferential entry of the cytotoxic...
9968619 Method of treating triple-negative breast cancer using thienotriazolodiazepine compounds  
A method of treating triple-negative breast cancer in a mammal comprising the step of: administering to a patient a pharmaceutical acceptable amount of a compound being a thienotriazolodiazepine...
9968606 Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereof  
The invention provides novel chemical compounds useful for treating cancer or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
9968570 Compositions and methods for treating cancer  
The present invention provides, in part, compositions and methods for treating cancer using a combination of C6-ceramide and other anti-cancer agents in certain vesicles.
9965585 Detection of genetic or molecular aberrations associated with cancer  
Systems, apparatus, and methods are provided for determining genetic or molecular aberrations in a biological sample. Biological samples including cell-free DNA fragments are analyzed to identify...
9964542 Bladder cancer detection composition, kit, and associated methods  
Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of bladder cancer in a subject are provided by detecting in a urine sample a combination of biomarkers. In one...
9963747 Methods for the identification, assessment, and treatment of patients with cancer therapy  
The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a...
9963746 Composition or kit for making a prognosis of liver cancer, and method for making a prognosis of liver cancer  
The present disclosure provides a marker for predicting prognosis of liver cancer, a composition or kit for predicting prognosis of liver cancer, preferably, a composition or kit for predicting...
9963703 Compositions and methods for treating pancreatic cancer  
Provided herein are composition for sensitizing tumors to anti-tumor therapies. The compositions include antisense oligonucleotides against TGFβ2, wherein the compositions sensitize tumors to...
9963701 Pharmaceutical composition for treatment of radiation- or drug-resistant cancer comprising HRP-3 inhibitor  
The present invention relates to a pharmaceutical composition for treating a radiation- or drug-resistant cancer, containing an agent capable of inhibiting the expression of hepatoma-derived...
9963695 Diagnosis of prostate cancer  
The invention provides methods for isolating RNA from whole urine and urine fractions for the diagnosis of prostate cancer and/or benign prostate hyperplasia. An exemplary method for diagnosing...
9963486 Peptidomimetics for treating HER2-overexpressed cancer  
Novel peptidomimetic compounds are disclosed, compounds that inhibit protein-protein interactions (PPI) of epidermal growth factor receptors (EGFR), also called human epidermal growth factor...
9963485 Cycloheptapeptide agents for treatment of cancer and obesity diseases  
New anticancer and anti-obesity agents based on cyclic peptide compounds are isolated from the stem barks of Maytenus variabilis (Loes.) C. Y. Cheng (Celastraceae). The invention also includes its...
9962403 Formulation drug of sodium ion and calcium ion for treating cancer, tumor and nonmalignancy  
The invention relates to a formulation cancer drug termed the “medicinal ion bomb” and its treatment methods. A mouse carcinoma, at 13mm x 13mm in size was killed by a single intratumoral...
9962373 Methods of treating bladder cancer  
The present invention provides methods and compositions for treating bladder cancer, including metastatic bladder cancer and non-muscle-invasive bladder cancer, by administering a composition...
9962341 Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer  
The present invention relates to an active pharmaceutical ingredient (API) which comprises or consists essentially of cannabidiol (CBD) and one other cannabinoid selected from cannabigerol (CBG),...
9962225 Method and apparatus for skin cancer thermal therapy  
An apparatus for treatment of soft tissue includes a source of radiation, a handpiece which is adapted to transmit radiation emitted from the source of radiation to a region of soft tissue,...
9958663 Light-trapping cancer cell stage testing method  
A light-trapping cancer cell stage testing method includes: measuring a first average escape velocity or range of first cancer cells and a second average escape velocity or range of second cancer...
9958447 Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation  
The invention provides a method of detecting the presence or absence of a disease in a patient wherein said disease is accompanied by deficient levels of S-adenosylmethionine comprising:...
9957575 Methods for detecting CpG methylation and for diagnosing cancer  
The present invention relates to the field of pharmacogenomics and in particular to detecting the presence or absence of hypermethylated DNA. The detection of CpG methylation in marker DNA is...
9957573 EML4-ALK translocations in lung cancer  
The present disclosure relates to methods for the diagnosis and evaluation of neoplastic disorders, particularly non-small cell lung cancer. Assays are described in which patient test samples are...
9957570 DNA hypermethylation diagnostic biomarkers for colorectal cancer  
The present invention relates to the field of cancer. More specifically, the present invention relates to the use of biomarkers to detect colorectal cancer. In one aspect, the present invention...
9957569 Recurrent gene fusions in prostate cancer  
Recurrent gene fusions in prostate cancer of androgen regulated genes or housekeeping genes and ETS family member genes are described. Compositions and methods having utility in prostate cancer...
9957302 Treating cancer with viral nucleic acid  
This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using...
9957301 Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response  
The invention relates to a kit of parts, suitable for use in a therapy of cancer, wherein said kit comprises: (i) a recombinant protein comprising one or several polypeptides bearing one or...
9957236 Selective inhibitors interfering with fibroblast growth factor receptor and FRS2 interaction for the prevention and treatment of cancer and other diseases  
The present technology relates to medicine and includes the use of inhibitors which selectively interfere with the interaction between a fibroblast growth factor receptor and FRS2, and with the...
9956305 Organ protection in PSMA-targeted radionuclide therapy of prostate cancer  
A method of reducing radiation exposure of a non-cancerous tissue of a patient diagnosed with a cancer includes administering to the patient an agent capable of competing for binding sites on a...
9956303 Anti-met therapy for previously diagnosed cancer patients  
The present invention relates to methods useful in the selection of cancer patients suitable for treatment with therapies directed at c-Met. The method employs imaging agents which comprise...
9956215 Methods of treating cancer with farnesyltransferase inhibitors  
The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma (“PTCL”), with a farnesyltransferase...
9956208 Compounds for the treatment of cancer and inflammatory diseases  
The present invention relates to novel compounds and pharmaceutical compositions thereof which may be useful in the treatment and/or prevention of various conditions. The present invention also...
9955898 Cancer diagnosis method using respiratory gas  
A method for diagnosing cancer, comprises detecting volatile organic compounds (VOCs) contained specifically in exhaled breath of cancer patients, and more particularly, to a method for providing...
9953129 Patient stratification and determining clinical outcome for cancer patients  
In a first aspect the present invention is directed to a method of generating a scheme allowing classification of a cancer of an individual patient for estimating a clinical outcome for said...
9952221 Methods for screening, predicting and monitoring prostate cancer  
Biomarkers are identified by analyzing gene expression data using support vector machines (SVM) to rank genes according to their ability to separate prostate cancer from normal tissue. Expression...
9951390 Prostate cancer prognostic compositions and kits  
Described herein are method, compositions and kits for prognosis of prostate cancer. The methods include determining the ratio of PCA3 and of a prostate-specific marker expression in a urine...
9951388 Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis  
In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or...
9951114 Recombinant cancer therapeutic cytokine  
Recombinant therapeutic cytokines (“therakines”) for the treatment of cancer are provided. The recombinant therakines include a truncated region of MDA-7/TL-24 (“M4”) not normally found in nature...
9951111 Type I interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis  
The subject invention pertains to agonist peptides of type I interferons and methods of using the peptides. These peptides are based on the amino acid sequence of the C-terminus region of the type...
9951056 Substituted nicotinamide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease  
Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer,...
9950070 HER2 aptamer-anticancer drug complex for cancer cell chemotherapy  
This invention relates to a complex for cancer cell chemotherapy and, more particularly, to a HER2 aptamer-anticancer drug complex for chemotherapy of cancer cells, which includes a nucleic acid...
9950021 Anti-cancer active substance from Antrodia camphorata, method for preparing the same and use thereof  
An anti-cancer active substance from Antrodia Cinnamomea, produced from mycelium of Antrodia Cinnamomea by following steps: (1) culturing mycelium of Antrodia Cinnamomea by liquid fermentation;...
9949984 Method for use of homopiperazinium compounds in the treatment of cancer  
A method for treating cancer comprising administering to a patient in need thereof an effective amount of a compound having the formula: wherein R1 and R2 are independently alkyl of 1 to 6 carbon...
9949956 Compounds, compositions, and methods for preventing metastasis of cancer cells  
Disclosed are methods for preventing metastasis of cancer cells. The disclosed compounds can be used to prevent the spread of tumor or other types of cancer cells.
9949474 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue  
A composition and method for generating reagents and the composition of these reagents for the stabilization and preservation of viability of cancer tissue which has been surgically excised and...
9945863 Coiled coil helix cristae morphology 1 (CHCM1) tumor marker and cancer therapeutic target  
Methods for diagnosing and treating a cancer or a tumor in a patient are provided. The methods can comprise the steps of obtaining a biological sample from the patient and analyzing the sample for...
9945862 Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds  
Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof (e.g., lenvatinib mesylate). The...
9945861 Methods for predicting the survival time of a patient suffering from a solid cancer based on density of B cells  
The present invention relates to a method for predicting the survival time of a patient suffering from a solid cancer comprising the steps consisting of i) determining the density of B cells at...
9945783 Cervical cancer information providing method and device  
Provided is a canceration information providing method capable of presenting the information related to canceration of the cells with high reliability. A cell in which the amount of DNA is greater...